FREMONT, Calif.--(BUSINESS WIRE)--Nov. 20, 2024--
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will participate at the following investor conferences:
-
Piper Sandler 36th Annual Healthcare Conference
Date:
Tuesday, December 3, 2024
Fireside Chat Time:
12:30 pm Eastern Time
Location:
The Lotte New York Palace in New York, NY
-
TD Cowen Diagnosing Tomorrow: Tools & Technologies for the Next Decade
Date:
Thursday, December 12, 2024
Panel Topic: MRD - The Future Tech Stack
Panel Time:1:30 pm Eastern Time
Location: OneVanderbilt in New York, NY
About Personalis, Inc.
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable the selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California. To learn more, visit www.personalis.com and connect with us on LinkedIn and X (Twitter).
View source version on businesswire.com:
https://www.businesswire.com/news/home/20241120667294/en/
Investors:
Caroline Corner
investors@personalis.com
415-202-5678
Media:
pr@personalis.com
Source: Personalis, Inc.
